CoChat

Prospective randomized study of thrice weekly six-month and nine-month chemotherapy for cervical tuberculous lymphadenopathy

YUEN, A, WONG, S, TAM, C, CHAN, S, WEI, W, LAU, S · 1997 · Otolaryngology - Head and Neck Surgery

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

The aim of this study is to compare the efficacy of a thrice weekly 6-month regimen, 4S3H3R3Z3/2H3R3 (which consists of an initial 4 months of streptomycin (S), isoniazid (H), rifampicin (R), and pyrazinamide (Z) followed by 2 months of isoniazid and rifampicin), with a thrice weekly 9-month regimen, 4S3H3R3Z3/5H3R3 (which consists of an initial 4 months of streptomycin, isoniazid, rifampicin, and pyrazinamide followed by 5 months of isoniazid and rifampicin), in the treatment of cervical tuberculous lymphadenopathy. A total of 113 patients were recruited between August 1987 and December 1993. Twenty-two patients were excluded from the analysis because of defaulting treatment or modification of regimen. Ninety-one patients were included in the analysis. Forty-three patients were given the 6-month regimen, and 48 patients were given the 9-month regimen. Two (5%) patients of the 6-month regimen and one (2%) patient of the 9-month regimen had primary failure after completion of treatment (relative risk, 2.23; 95% confidence interval, 0.21 to 23.76). Of the 88 patients who had initial clinical remission after completion of treatment, the 5-year actuarial remission rates were 89% for the 6-month regimen and 90% for the 9-month regimen (Wilcoxon, p = 0.44). There were no significant differences of both primary failure rate and 5-year actuarial remission rate of the two regimens. The 6-month regimen is recommended as the initial treatment of tuberculous lymphadenopathy.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0194-5998(97)70323-1

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Cited by

See all 55

Metadata

Authors
YUEN, A., WONG, S., TAM, C., CHAN, S., WEI, W., & LAU, S.
Affiliations
Queen Mary Hospital (CN)
ORCID
WEI, W
Venue
Otolaryngology - Head and Neck Surgery
Publisher
Wiley
Published
1997-02
Volume
116
Issue
2
Pages
189-192
ISSN
  • 0161-6439 (ISSN-L)
  • 0194-5998
OpenAlex
W1974353709
Cited by
48
References
19
Citations by year
2024: 2 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 5 · 2018: 4 · 2017: 1 · 2016: 1 · 2014: 1 · 2013: 2 · 2012: 1
FWCI
0.87
Type
journal article
Language
en
Open access
closed
Locations
  • Otolaryngology (publishedVersion)
  • PubMed (publishedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
  • PubMed
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
tuberculosis chemotherapy, streptomycin, isoniazid, rifampicin, pyrazinamide, primary treatment failure, clinical remission, treatment duration
MeSH terms
Administration, Oral, Adult, Antibiotics, Antitubercular, Biopsy, Needle, Female, Humans, Injections, Intramuscular, Isoniazid, Male, Middle Aged, Mycobacterium tuberculosis, Neck, Prospective Studies, Retrospective Studies, Rifampin, Streptomycin, Tuberculosis, Lymph Node, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prospective randomized study of thrice weekly six-month and nine-month chemotherapy for cervical tuberculous lymphadenopathy. https://app.cochat.ai/papers/10.1016/s0194-5998(97)70323-1
The paper
YUEN, A., WONG, S., TAM, C., CHAN, S., WEI, W., & LAU, S. (1997). Prospective randomized study of thrice weekly six-month and nine-month chemotherapy for cervical tuberculous lymphadenopathy. Otolaryngology - Head and Neck Surgery. https://doi.org/10.1016/s0194-5998(97)70323-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.